Your browser doesn't support javascript.
loading
HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease
Pacheco, Matheus Alves; Cardoso, Silvia Meyer; Honicky, Michele; Moreno, Yara Maria Franco; Lima, Luiz Rodrigo Augustemak de; Marcos, Camila Souza; Back, Isabela de Carlos.
  • Pacheco, Matheus Alves; Universidade Federal de Santa Catarina. Florianopolis. BR
  • Cardoso, Silvia Meyer; Universidade Federal de Santa Catarina. Florianopolis. BR
  • Honicky, Michele; Universidade Federal de Santa Catarina. Florianopolis. BR
  • Moreno, Yara Maria Franco; Universidade Federal de Santa Catarina. Florianopolis. BR
  • Lima, Luiz Rodrigo Augustemak de; Universidade Federal de Alagoas. Maceió. BR
  • Marcos, Camila Souza; Universidade Federal de Santa Catarina. Florianopolis. BR
  • Back, Isabela de Carlos; Universidade Federal de Santa Catarina. Florianopolis. BR
Int. j. cardiovasc. sci. (Impr.) ; 35(6): 784-793, Nov.-Dec. 2022. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1405208
ABSTRACT
Abstract Background Children and adolescents with congenital heart disease may be more likely to develop atherogenic cardiovascular diseases in adulthood. Therefore, the early identification of risk factors and intervention in childhood may be crucial for a good quality of life and longevity. Objectives To describe the distribution of high-density lipoprotein-cholesterol (HDL-c) levels and its association with socioeconomic, clinical and cardiovascular risk factors in children and adolescents with congenital heart disease. Methods Cross-sectional study with children and adolescents aged between 5 and 18 years, with congenital heart disease. Socioeconomic, clinical and cardiovascular risk factors were evaluated. HDL-c concentrations were evaluated by the direct method and categorized as desirable (>45 mg/dL), borderline (40-45 mg/dL) and low (<40 mg/dL). We also assessed the "undesirable" levels, consisting of the sum of "borderline" and "low" values for comparative purposes. The multivariate logistic regression analysis was used to evaluate the factor associated with undesirable HDL-c levels. A p<0.05 value was adopted as statistically significant. Results Mean HDL-c was 51.2 mg/dL (SD 12.6), with a prevalence of 33.2% of undesirable HDL-c. In the multivariate analysis, C-reactive protein levels ≥ 3mg/dL (OR 3.26; 95% CI 1.32-8.04), age ≥ 10 years old (OR 2.11; 95% CI 1.12-3.99) and undesirable levels of triglycerides (OR 2.21; 95% CI 1.13-4.75) were associated with undesirable HDL-c. Conclusion In this sample of children and adolescents with congenital heart disease, almost one third presented low or borderline HDL-c levels. Age ≥10 years, C-reactive protein and triglycerides were associated with undesirable HDL-c levels. These factors should be considered in the prevention of cerebrovascular diseases in adulthood in this population.


Full text: Available Index: LILACS (Americas) Type of study: Observational study / Prognostic study / Risk factors Language: English Journal: Int. j. cardiovasc. sci. (Impr.) Journal subject: Cardiology Year: 2022 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal de Alagoas/BR / Universidade Federal de Santa Catarina/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Type of study: Observational study / Prognostic study / Risk factors Language: English Journal: Int. j. cardiovasc. sci. (Impr.) Journal subject: Cardiology Year: 2022 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal de Alagoas/BR / Universidade Federal de Santa Catarina/BR